» Articles » PMID: 1769691

Vitamin D3 Binding Protein Required for in Vitro Activation of Macrophages After Alkylglycerol Treatment of Mouse Peritoneal Cells

Overview
Journal Immunology
Date 1991 Nov 1
PMID 1769691
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro treatment of peritoneal cells with dodecylglycerol (DDG) in 10% foetal calf serum (FCS) supplemented medium RPMI-1640 results in a greatly enhanced Fc receptor-mediated phagocytic activity of macrophages. This macrophage activation process requires a serum factor in the alpha 2-globulin fraction. When mouse peritoneal cells were treated with 50 ng DDG/ml in a serum-free 0.1% egg albumin-supplemented medium RPMI-1640 (EA medium) for 30 min and cultured in EA medium containing electrophoretically fractionated alpha 2-globulin for 3 hr, a markedly enhanced activation of macrophages was observed. To improve fractionation of alpha 2-globulin, FCS was first precipitated with 50% saturated ammonium sulphate and then the supernatant electrophoretically fractionated. The resultant alpha 2-globulin fraction was unable to support activation of macrophages. Vitamin D3 binding protein (DBP) of the alpha 2-globulin fraction is known to be precipitable by 50% saturated ammonium sulphate. When human alpha 2-globulin was treated with antiserum against human DBP and used in a medium for cultivation of DDG-treated peritoneal cells, no significant activation of macrophages was observed. Cultivation of DDG-treated peritoneal cells in a medium containing a low concentration of purified human DBP (group specific component, Gc) produced a greatly enhanced ingestion activity of macrophages. Purified human Gc protein, when used in an EA medium for step-wise cultivation of DDG-treated B and untreated T cells, was efficiently converted to a macrophage-activating factor.

Citing Articles

Production of GcMAF with Anti-Inflammatory Properties and Its Effect on Models of Induced Arthritis in Mice and Cystitis in Rats.

Kirikovich S, Levites E, Proskurina A, Ritter G, Dolgova E, Ruzanova V Curr Issues Mol Biol. 2024; 46(10):10934-10959.

PMID: 39451530 PMC: 11506609. DOI: 10.3390/cimb46100650.


Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Mondal G, Saroha A, Bose P, Chatterjee B Glycoconj J. 2016; 33(2):209-18.

PMID: 27034286 DOI: 10.1007/s10719-016-9658-2.


An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia.

Ahmad Y, Sharma N, Garg I, Ahmad M, Sharma M, Bhargava K PLoS One. 2013; 8(7):e67548.

PMID: 23844025 PMC: 3699623. DOI: 10.1371/journal.pone.0067548.


Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Toyohara Y, Hashitani S, Kishimoto H, Noguchi K, Yamamoto N, Urade M Oncol Lett. 2012; 2(4):685-691.

PMID: 22848250 PMC: 3406437. DOI: 10.3892/ol.2011.306.


An update on the therapeutic role of alkylglycerols.

Iannitti T, Palmieri B Mar Drugs. 2010; 8(8):2267-300.

PMID: 20948908 PMC: 2953404. DOI: 10.3390/md8082267.


References
1.
Yamamoto N, Homma S, Millman I . Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol. 1991; 147(1):273-80. View

2.
Yamamoto N, St Claire Jr D, Homma S, Ngwenya B . Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res. 1988; 48(21):6044-9. View

3.
Yamamoto N, Ngwenya B . Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids. Cancer Res. 1987; 47(8):2008-13. View

4.
Cooke N . Rat vitamin D binding protein. Determination of the full-length primary structure from cloned cDNA. J Biol Chem. 1986; 261(7):3441-50. View

5.
Finkelman F, Potter M . Plasmacytomas and murine immunoglobulins. Methods Enzymol. 1985; 116:121-45. DOI: 10.1016/s0076-6879(85)16009-x. View